The Efficacy and Tolerability of Canagliflozin in Healthy Individual
Status:
COMPLETED
Trial end date:
2024-06-29
Target enrollment:
Participant gender:
Summary
The primary objective is to measure the effects that canagliflozin intervention has on reducing average glucose in healthy individuals.
The secondary objective is to assess the tolerability and side effects and urinary glucose excretion following the pulsatile dosing protocol.